Autres langues Burning Rock Biotech Limited

Actions

BNR

US12233L2060

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 20/07/2026			Varia. 5j.	Varia. 1 janv.
10,07 ^USD	+1,00%		-10,88%	-50,02%

02/07	Burning Rock Biotech : un dirigeant acquiert des actions pour un montant de 6 182 172 dollars, selon un document de la SEC	MT
09/06	Burning Rock Biotech Limited publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

02/07	Burning Rock Biotech Insider Bought Shares Worth $6,182,172, According to a Recent SEC Filing
02/07	Burning Rock Announces Founder’s Purchase of Its ADSs
09/06	Burning Rock Reports First Quarter 2026 Financial Results
09/06	Burning Rock Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
28/04	Burning Rock Publishes 2025 Annual Report on Form 20-F
13/04	Aurelion Inc. Announces Executive Changes, Effective April 13, 2026
02/04	Burning Rock Biotech Insider Bought Shares Worth $5,466,143, According to a Recent SEC Filing
02/04	Burning Rock Announces Founder’s Purchase of Its ADSs
13/03	Burning Rock Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
12/03	Burning Rock Biotech : Fourth Quarter 2025 Presentation Slides
12/03	Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results
26/01	Burning Rock Biotech : Milestone in Precision Oncology! Burning Rock Dx’s Breast Cancer NGS CDx Kit Enters the CMDE Priority Review Channel
06/01	Burning Rock Biotech : Liquid Biopsy Technology Granted U.S. Patent, Accelerating Global Layout in Precision Diagnosis
05/01	Burning Rock Announces Founder’s Purchase of Its ADSs
23/12	Burning Rock Announces Results of 2025 Annual General Meeting
18/12	From Accreditation to Excellence: Webinar Highlights on CAP, CLIA, and Quality Systems in Clinical Laboratories
01/12	Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025
01/12	Burning Rock Biotech : BR - 2025 AGM - Notice of AGM (cfb8ff)
20/11	Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
20/11	Burning Rock Reports Third Quarter 2025 Financial Results
20/11	Burning Rock Biotech : Q3 2025 Presentation Slides
24/09/25	Burning Rock's System Approved in Japan as Companion Diagnostic for AstraZeneca's Capivasertib
24/09/25	Riken Genesis Co., Ltd. Announces OncoGuide OncoScreen Plus CDx System Now Approved in Japan as A Companion Diagnostic for Capivasertib in Breast Cancer
24/09/25	Burning Rock's Oncoguide(TM) Oncoscreen(TM) Plus CDX System now approved in Japan as a companion diagnostic for capivasertib in breast cancer
24/09/25	Burning Rock Biotech : OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer